arlo

  • Alumni

Submitted

Celgene – The Business of Performing Miracles
arlo
Last modified on December 9, 2015 at 7:10 pm
The business model for biotech is simple: discover and develop therapies and sell them at high-enough margins to justify the costs until the patent expires. The larger the unmet need and the more effective the therapy, the more value is [...]

Activity Feed

On December 13, 2015, arlo commented on Tesla – Winner winner chicken dinner :

Great article – very thorough analysis! I think it’s also interesting to note that Model S and X are effectively the same chassis, further reducing complexity in operations, increasing automation and decreasing overall costs. The direct to consumer model also minimizes channel conflicts, if regulation passes.

On December 10, 2015, arlo commented on Pixar Animation Studios: Creative Kaizen :

Huzzah.

On December 10, 2015, arlo commented on Reprogramming cells to fight disease: Rewriting the rules of biopharma R&D :

The future of medicine.

On December 10, 2015, arlo commented on VALEANT: Valiant Vendor or Voracious Villain? :

Valeant is just another predatory pharmaco preying on poor patients.